Lots More Information

Related Articles

Sources

  • National Institute of Neurological Disorders and Stroke Web site. http://www.ninds.nih.gov/disorders/parkinsons_disease/detail_parkinsons_disease.htm#105553159.
  • Shults, C.W., Oakes, D., Kieburtz, K., et al. (2002). Effects of coenzyme Q 10 in early Parkinson's disease. Evidence in slowing of the functional decline. Arch Neurol, 1541-1550.
  • Bender, A. (2006). Creatine supplementation in Parkinson disease: a placebo-controlled randomized pilot trial. Neurology, 67(7):1262-4.
  • NINDS NET-PD Investigatos. A randomized, double-blind, futility clinical trial of creatine and minocycline in early Parkinson disease. Neurology, 66(5):664-71.
  • Seaton, T.A. (1996). Thioctic acid does not restore glutathione levels or protect against the potentiation of 6-hydroxydopamine toxicity induced by glutathione depletion in rat brain. J Neural Transm, 103(3):315-29.
  • Bharat, S. (2002). Pre-treatment with R-lipoic acid alleviates the effects of GSH depletion in PC12 cells: implications for Parkinson's disease therapy. Neurotoxicology, 23(4-5):479-86.
  • Bilska, A. (2007). Alpha-lipoic acid differently affects the reserpine-induced oxidative stress in the striatum and prefrontal cortex of rat brain. Neuroscience, 146(4):1758-71.
  • Seaton, T.A. (1996). The isomers of thioctic acid alter C-deoxyglucose incorporation in rat basal ganglia. Biochem Pharmacol, 51(7):983-6.
  • Etminan, M. (2005). Intake of vitamin E, vitamin C, and carotenoids and the risk of Parkinson's disease: a meta-analysis. Lancet Neurol, 4(6):362-5.